Precise Chemipharma

What Precise Chemipharma does

Precise Chemipharma Private Limited is a Mumbai-based pharmaceutical manufacturer founded in 1997 by Mr. Pravin Shah, operating as a privately held company under the Precise Group umbrella. The company manufactures Active Pharmaceutical Ingredients (APIs), Ready-to-fill Drug Pellets, and Finished Pharmaceutical Formulations across therapeutic areas including cardiovascular, anti-diabetics, analgesics, anti-bacterials, anti-allergics, respiratory, and anti-diarrhoeals. Its core technological differentiation centers on proprietary pellet technology producing spheroidal pellets for maximum drug effect in blood plasma with reduced adverse effects, combined with customized release profile capabilities (sustained or pulsed). The company's FDA WHO-CGMP accredited manufacturing facility in Nashik, Maharashtra spans 32,000 square feet with 38 separate Air Handling Units across tablet, capsule, and pellet sections.

The company operates a B2B contract-based revenue model with four primary revenue streams: API manufacturing and supply, drug pellet production, finished formulation manufacturing, and Point-to-Point (P2P) / contract manufacturing services for DCGI-approved products. Pricing is not publicly disclosed and operates on direct enterprise field sales terms. The company holds approved API supplier status with Tier-1 generic pharmaceutical manufacturers including ABBOTT, SUN PHARMA, TEVA, RANBAXY, Dr. REDDY's, and PLIVA, and exports to approximately 30 countries spanning Europe, Latin America, the Middle East, and Asia with registered products in 15 countries. Regulatory affairs expertise covering Drug Master Files (DMF), CTD-EDMF, COPP, and bioequivalence study management is positioned as a core capability supporting market entry into regulated and semi-regulated geographies.

The company holds Government of India Recognised Export House status and operates with a workforce of over 100 professionals including a specialized R&D team of approximately 100 medical workers. Disclosed annual turnover stands at $40 million USD per the company website. Recent strategic activity includes the 2024 commissioning of a new state-of-the-art formulations and pellet plant at Nashik, signaling capacity expansion to support growing contract manufacturing demand. The business is founder-controlled with no disclosed external institutional investors, private equity backing, or public market listings.

Name

Precise Chemipharma

Legal name

Precise Chemipharma Private Limited

Website

https://precisechemipharma.com

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

11–50 employees

Short description

Precise Chemipharma is a Mumbai-based B2B pharmaceutical manufacturer founded in 1997, producing Active Pharmaceutical Ingredients (APIs), Ready-to-fill Drug Pellets, and Finished Formulations for major pharmaceutical companies across approximately 30 countries.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Small-Molecule API Commercial Manufacturing (HLAGAHAB)

akta.pro secondary industries

Generic APIs & Intermediates (Active Ingredients) (HLAIABAG), GMP Scale-Up, Tech Transfer & Process Validation (PPQ) (HLAGAHAL), Generic ANDA/Regulatory Affairs & Submissions (HLAIABAJ)

Keywords

• Pharmaceutical manufacturing
• Active pharmaceutical ingredients
• Drug pellets
• Finished pharmaceutical formulations
• Contract manufacturing

Headquarters

HQ city

Mumbai

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Infrastructure, Marketing or Sales

Revenue model

1. Active Pharmaceutical Ingredients (API) Manufacturing: Manufacturing and supply of Active Pharmaceutical Ingredients to pharmaceutical manufacturers including major companies like ABBOTT, SUN PHARMA, TEVA, RANBAXY, Dr. REDDY's, PLIVA.
2. Drug Pellets (Ready-to-fill): Production and sale of ready-to-fill drug pellets for various therapeutic applications including cardiovascular, anti-diabetics, and other critical medical conditions.
3. Finished Pharmaceutical Formulations: Manufacturing of finished dosage formulations including tablets, capsules (including soft-gel), and pellets for various therapeutic areas.
4. P2P and Contract Manufacturing Services: Peer-to-peer and contract manufacturing services for new products with DCGI approvals. Focus on high value niche products with first launch advantages in certain cases.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

Precise Chemipharma manufactures Active Pharmaceutical Ingredients (APIs), Ready-to-fill Drug Pellets, and Finished Pharmaceutical Formulations at its FDA WHO-CGMP accredited facility in Nashik, India. The company supplies approved APIs to major pharmaceutical manufacturers including ABBOTT, SUN PHARMA, TEVA, RANBAXY, Dr. REDDY's, and PLIVA, and also offers P2P (Point-to-Point) and contract manufacturing services for niche products with DCGI approvals.

Product overview

Precise Chemipharma operates as a pharmaceutical manufacturer offering three core product lines: Active Pharmaceutical Ingredients (API), Drug Pellets (Ready-to-fill), and Finished Pharmaceutical Formulations. The company manufactures niche products including APIs such as Zolpidem, Dorzolamide, Levocloperastine, and Naphazoline; pellets like Rabeprazole Sodium EC, Orlistat, Tamsulosin HCL SR, Omeprazole Pellets, and Desvenlafaxine Succinate; and finished formulations including Febuxostat Tablets, Tapentadol Tablets, Flupirtine Maleate Capsules, Agomelatine Tablets, and Ilaprazole Tablets. Additionally, the company provides P2P (Point-to-Point) and contract manufacturing services for products with DCGI approvals. The manufacturing hub located near Mumbai (Nashik) produces tablets, capsules (including soft-gel), and pellets across therapeutic areas including Anti-Biotics, Anti-Allergic, Respiratory, Cardiovascular, Analgesic, Anti-Diarrhoeals, Anti-Diabetics, and Anti-Bacterials.

Differentiator

Problem solved

Functional benefit

Products and services

• Finished Pharmaceutical Formulations WHO-GMP certified manufacturing of niche finished dosage formulations including tablets and capsules used for cardiovascular ailments, anti-diabetics, and other critical medical states. Specific formulations include Febuxostat Tablets, Tapentadol Tablets, Flupirtine Maleate Capsules, Agomelatine Tablets, and Ilaprazole Tablets.
• Drug Pellets (Ready-to-fill) Ready-to-fill drug pellets including Rabeprazole Sodium EC, Orlistat, Tamsulosin HCL SR, Omeprazole Pellets, Desvenlafaxine Succinate, Bazidoxifene, Tamsulosin HCl, and Esomeprazole. Spheroidal pellet technology ensures maximum drug effect in blood plasma with minimal adverse effects; pellets can be filled into gelatin capsules, sachets, or compressed into tablets.
• Active Pharmaceutical Ingredients (API) Manufacturing of Active Pharmaceutical Ingredients including Zolpidem, Dorzolamide, Levocloperastine, and Naphazoline at the company's own licensed manufacturing facility. APIs are supplied as approved supplier to major pharmaceutical companies.
• P2P and Contract Manufacturing Services Point-to-Point (P2P) and contract manufacturing services for new products with DCGI approvals, focused on high-value niche products. Services include regulatory document support such as Drug Master Files, Certificate of Analysis, and COPP.

Quantifiable outcome

• Annual turnover of 40 million USD
• +2 more outcomes

Named customers6 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators5 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Aurobindo Pharma: Large vertically integrated Indian pharmaceutical company manufacturing APIs, intermediates, and finished formulations. Operates in the same regulatory and customer space as Precise, with substantially greater scale and broader product portfolio.
• Piramal Pharma Solutions: Indian-based contract development and manufacturing organization (CDMO) offering API development, manufacturing, and formulation services. Comparable in providing contract manufacturing services to global pharma players, with broader scope including biologics.
• Ipca Laboratories: Indian pharmaceutical company manufacturing APIs, formulations, and intermediates across therapeutic areas. Overlaps with Precise on API manufacturing for global generic clients, though at meaningfully larger scale.
• Divi's Laboratories: One of India's largest API manufacturers with significant global reach across generic and custom API manufacturing. Operates in the same small-molecule API and intermediates space as Precise, but at substantially larger scale with broader customer base.

Direct peers

• Granules India: Indian pharmaceutical manufacturer focused on APIs, pellets, and finished formulations. Highly comparable business model to Precise Chemipharma, with a similar emphasis on ready-to-fill pellets and contract manufacturing for global generic players.
• SMS Pharmaceuticals: Indian API and intermediate manufacturer serving global generic pharma companies. Highly comparable in product mix (APIs and intermediates for cardiovascular, CNS, anti-infectives) and customer profile to Precise Chemipharma.
• Neuland Laboratories: India-based API manufacturer and contract development organization offering APIs, custom synthesis, and generic finished dosages. Directly comparable to Precise in customer base (generic pharma manufacturers) and service offerings including DMF/regulatory support.
• Hikal Ltd: Indian manufacturer of APIs, intermediates, and contract research services for global pharmaceutical and agrochemical customers. Comparable in offering APIs and intermediates to global pharma majors with similar regulatory focus.

Regional players

• Sequent Scientific: Indian pharmaceutical company focused on APIs and finished formulations for animal and human health. Operates in similar API manufacturing space but with a different primary end-market (animal health focus).

Emerging players

• CTX Lifesciences: Indian API manufacturer offering small-molecule APIs and contract manufacturing services to global pharmaceutical companies. Comparable in scale, service offering, and target customer base to Precise Chemipharma.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/precise-chemipharma-pvt-ltd

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Precise Chemipharma